Published in Crit Care Med on November 01, 2011
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med (2014) 2.44
Septic Shock: Advances in Diagnosis and Treatment. JAMA (2015) 2.37
Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med (2015) 2.09
Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis. Crit Care Med (2014) 1.72
Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med (2014) 1.56
A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med (2014) 1.53
A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med (2015) 1.50
Glucocorticoid Receptor Expression in Peripheral WBCs of Critically Ill Children. Pediatr Crit Care Med (2015) 1.41
Genome-wide expression profiling in pediatric septic shock. Pediatr Res (2013) 1.39
Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care (2012) 1.31
Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med (2014) 1.25
Clinical review: sepsis and septic shock--the potential of gene arrays. Crit Care (2012) 1.25
Genetics and genomics in pediatric septic shock. Crit Care Med (2012) 1.23
Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One (2014) 1.22
Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock. Am J Respir Crit Care Med (2014) 1.20
Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin (2013) 1.19
The temporal version of the pediatric sepsis biomarker risk model. PLoS One (2014) 1.02
Identifying critically ill patients who may benefit from adjunctive corticosteroids: not as easy as we thought. Pediatr Crit Care Med (2014) 1.00
Identification of sepsis subtypes in critically ill adults using gene expression profiling. Crit Care (2012) 0.94
Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock. Crit Care (2014) 0.91
Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med (2013) 0.91
Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol (2015) 0.89
Postnatal Age Is a Critical Determinant of the Neonatal Host Response to Sepsis. Mol Med (2015) 0.88
Improving risk classification of critical illness with biomarkers: a simulation study. J Crit Care (2013) 0.87
Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies. Clin Dev Immunol (2012) 0.85
Simplification of a Septic Shock Endotyping Strategy for Clinical Application. Am J Respir Crit Care Med (2017) 0.82
Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children. BMC Med Genomics (2012) 0.79
Sepsis in transit: from clinical to molecular classification. Crit Care (2012) 0.78
Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients. Crit Care (2016) 0.77
Risk Stratification and Prognosis in Sepsis: What Have We Learned from Microarrays? Clin Chest Med (2016) 0.76
Novel diagnostics for sepsis: a decade of promise for gene expression profiling. Crit Care Med (2011) 0.76
Sepsis in Pediatric Cardiac Intensive Care. Pediatr Crit Care Med (2016) 0.75
Emerging infection and sepsis biomarkers: will they change current therapies? Expert Rev Anti Infect Ther (2016) 0.75
Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies. Pediatr Crit Care Med (2017) 0.75
Host-based Peripheral Blood Gene Expression Analysis for the Diagnosis of Infectious Diseases. J Clin Microbiol (2016) 0.75
Pediatric Sepsis Endotypes Among Adults With Sepsis. Crit Care Med (2017) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med (2005) 13.40
A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
Immunotherapy for sepsis--a new approach against an ancient foe. N Engl J Med (2010) 3.62
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med (2008) 3.48
Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics (2007) 3.37
Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med (2009) 3.16
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest (2009) 2.92
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics (2003) 2.92
Biomarkers of sepsis. Crit Care Med (2009) 2.88
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother (2006) 2.86
Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med (2010) 2.83
Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med (2007) 2.58
Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock (1998) 2.51
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood (2009) 2.50
The Pediatric Risk of Mortality III--Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr (1997) 2.39
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med (2005) 2.26
Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med (2009) 2.23
Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med (2009) 2.04
Leukocyte subset-derived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med (2010) 2.01
Validating the genomic signature of pediatric septic shock. Physiol Genomics (2008) 1.96
Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med (2008) 1.82
Sepsis: rethinking the approach to clinical research. J Leukoc Biol (2008) 1.80
The host response to sepsis and developmental impact. Pediatrics (2010) 1.62
Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med (2010) 1.51
Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care (2010) 1.48
Readmission and late mortality after pediatric severe sepsis. Pediatrics (2009) 1.38
Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling. J Thromb Haemost (2006) 1.35
Pediatric septic shock treatment: new clues from genomic profiling. Pharmacogenomics (2007) 1.22
Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit. Pediatr Crit Care Med (2009) 1.22
Steroid therapy of septic shock. Crit Care Clin (2009) 0.98
Influence of multiple organ dysfunction syndrome on duration of critical illness and hospitalization. Arch Surg (1996) 0.86
High-throughput DNA methylation profiling using universal bead arrays. Genome Res (2006) 8.05
Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med (2015) 4.90
Videos in clinical medicine. Central venous catheterization. N Engl J Med (2007) 3.77
Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med (2013) 3.73
Computerized physician order entry and medication errors in a pediatric critical care unit. Pediatrics (2004) 3.59
Videos in clinical medicine. Central venous catheterization--subclavian vein. N Engl J Med (2007) 3.43
Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics (2007) 3.37
Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA (2005) 3.29
Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA (2005) 3.21
Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med (2009) 3.16
Characterizing degree of lung injury in pediatric acute respiratory distress syndrome. Crit Care Med (2015) 2.85
Videos in clinical medicine. Pelvic examination. N Engl J Med (2007) 2.77
Videos in clinical medicine. Lumbar puncture. N Engl J Med (2006) 2.66
A Case-Control Study on the Impact of Ventilator-Associated Tracheobronchitis in the PICU. Pediatr Crit Care Med (2015) 2.65
Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med (2011) 2.59
Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med (2007) 2.58
Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med (2009) 2.23
Videos in Clinical Medicine. Placement of an arterial line. N Engl J Med (2006) 2.21
Extracorporeal life support for severe respiratory failure in children with immune compromised conditions. Pediatr Crit Care Med (2008) 2.17
Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med (2015) 2.09
Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med (2015) 2.09
Jading in the pediatric intensive care unit: Implications for healthcare providers of medically complex children. Pediatr Crit Care Med (2004) 2.06
Continuous propofol infusion in 142 critically ill children. Pediatrics (2002) 2.04
Leukocyte subset-derived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med (2010) 2.01
Clinical decision support systems in the pediatric intensive care unit. Pediatr Crit Care Med (2009) 2.00
The pediatric sepsis biomarker risk model. Crit Care (2012) 1.99
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med (2012) 1.99
In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood (2005) 1.99
Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol (2007) 1.96
Validating the genomic signature of pediatric septic shock. Physiol Genomics (2008) 1.96
The ideal time interval for critical care severity-of-illness assessment. Pediatr Crit Care Med (2013) 1.91
Care models and associated outcomes in congenital heart surgery. Pediatrics (2011) 1.90
Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol (2002) 1.88
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol (2006) 1.83
Admission angiopoietin levels in children with septic shock. Shock (2007) 1.82
Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med (2008) 1.82
Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg (2006) 1.81
Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med (2014) 1.81
Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy. Intensive Care Med (2011) 1.79
Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol (2002) 1.78
Corticosteroid exposure in pediatric acute respiratory distress syndrome. Intensive Care Med (2015) 1.77
Do outcomes vary according to the source of admission to the pediatric intensive care unit? Pediatr Crit Care Med (2008) 1.74
Retrospective analysis of the prognostic value of electroencephalography patterns obtained in pediatric in-hospital cardiac arrest survivors during three years. Pediatr Crit Care Med (2007) 1.74
Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med (2013) 1.74
Videos in clinical medicine. Bone marrow aspiration and biopsy. N Engl J Med (2009) 1.72
Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis. Crit Care Med (2014) 1.72
Comparison of SpO2 to PaO2 based markers of lung disease severity for children with acute lung injury. Crit Care Med (2012) 1.71